Tilus, Mercilyn G.

HRN: 03-96-19  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/11/2024
CO-AMOXICLAV 625MG (TAB)
01/11/2024
01/17/2024
PO
625mgtqb
Q8
Cap Lr
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: